semaglutide and osteoporosis Effects of Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice Effects of Glucagon-Like Peptide-1 receptor

10.15275/ssmj2103340 51

In a cohort of 7 patients with DT2 and obesity, daily use of liraglutide 1.2mg achieved, after 10 weeks, a weight reduction of 5% and a decrease in BMI of 2kg/m2.80 In another study, 3 patients with DT2 and obesity achieved a decrease in BMI of between 0.8 and 3.8kg/m2 after 18 weeks with this same dose of liraglutide.81 Another 2 patients with obesity and DT2 achieved weight losses of more than 5kg and a decrease in BMI of 1.5 and 2kg/m2 after 6 weeks of treatment.82 Finally, in a series of 20 subjects with obesity and DT2, an average weight loss of 4.7kg was reported after 8 weeks of treatment with liraglutide 1.8mg.83 In most of these patients, improvements in the psoriasis area severity index (PASI) was observed, and on occasions, a decrease in psoriatic plaques

Let's dive into this edition with the FDA's approval of semaglutide for the treatment of MASH

Both are popular peptides that help your body produce more growth hormone, but they dont work the same way

This variability in outcomes likely stems from differences in study design, population characteristics, and follow-up duration